Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Steven R. Hwang"'
Autor:
Steven R Hwang, Yuxiang Wang, Erika L Weil, Anand Padmanabhan, Theodore E Warkentin, Rajiv K Pruthi
Publikováno v:
Platelets, Vol 32, Iss 7, Pp 936-940 (2021)
Spontaneous heparin-induced thrombocytopenia (HIT) syndrome, characterized by clinical and serologic features of HIT despite the absence of proximate heparin exposure, can be triggered by total knee arthroplasty (TKA). A 56-year-old female receiving
Externí odkaz:
https://doaj.org/article/7a048c891e224666b124a62ee750b81d
Autor:
Rahul S. Bhansali, Fredrik Ellin, Miao Cao, Thomas Relander, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R Hwang, N. Nora Bennani, Julio C. Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine Zain, Miguel Ruiz, Jonathan E Brammer, Rishab Prakash, Swami P. Iyer, Adam J. Olszewski, Ajay Major, Sonali M. Smith, Peter A. Riedell, Caroline Goldin, Bradley M. Haverkos, Bei Hu, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M Goodman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita Dwivedy Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Publikováno v:
Blood. 140:1481-1484
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69b2196b50b3e2a198c4251230b77c07
https://doi.org/10.1182/blood-2022-160090
https://doi.org/10.1182/blood-2022-160090
Autor:
Jennifer Jane Gile, Allison M. Bock, Reema K. Tawfiq, Melissa C. Larson, Kittika Poonsombudlert, Seth M. Maliske, Matthew J. Maurer, James R. Cerhan, Brian Kabat, Brianna Gysbers, Katherine Smith, Steven R Hwang, David J. Inwards, Jonas Paludo, Stephen M. Ansell, Thomas M. Habermann, Sabarish Ayyappan, Thomas E. Witzig, Grzegorz S. Nowakowski, Umar Farooq, Yucai Wang
Publikováno v:
Blood. 140:6517-6519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91d7c5a873474965ef4976e10ab6198a
https://doi.org/10.1182/blood-2022-165419
https://doi.org/10.1182/blood-2022-165419
Autor:
Jacqueline F Wang, Steven R Hwang, Yi Jiang, Xinyue Qi, Shijia Zhang, Sameer A. Parikh, Wei Ding, Saad S. Kenderian, Eli Muchtar, Paul J. Hampel, Jose F. Leis, Javier L Munoz, Gita Thanarajasingam, Jonas Paludo, David J. Inwards, Grzegorz S. Nowakowski, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Neil E. Kay, Shouhao Zhou, Yucai Wang
Publikováno v:
Blood. 140:9882-9884
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b6cba6c5f2dca4637ef5623baf10916
https://doi.org/10.1182/blood-2022-168152
https://doi.org/10.1182/blood-2022-168152
Autor:
Bei Hu, Shebli Atrash, Leah Cohen, Stefan K. Barta, Yumeng Zhang, Lubomir Sokol, Amy Ayers, Luis E Malpica Castillo, Steven R Hwang, N. Nora Bennani, David Wada, Aung M Tun, Tamara K. Moyo, Nilanjan Ghosh, Michi M Shinohara
Publikováno v:
Blood. 140:1488-1490
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e63e64a0f798e2e4d6c1cce80131286
https://doi.org/10.1182/blood-2022-166887
https://doi.org/10.1182/blood-2022-166887
Autor:
Steven R Hwang, Yucai Wang, Kari G Rabe, Rong He, Saad S. Kenderian, Eli Muchtar, Paul J. Hampel, Neil E. Kay, Timothy G. Call, Amber Koehler, Amy L Behnken, Jose F. Leis, Esteban Braggio, Min Shi, David S. Viswanatha, Daniel L. Van Dyke, Susan L. Slager, Sameer A. Parikh, Wei Ding
Publikováno v:
Blood. 140:12390-12392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::176c76729dcf3e245cf483a489190420
https://doi.org/10.1182/blood-2022-165508
https://doi.org/10.1182/blood-2022-165508
Publikováno v:
Hematology/Oncology Clinics of North America. 36:365-380
Over the past decade, the role of immunotherapy treatment in cancer has expanded; specifically, indications for immune checkpoint inhibitors (ICI) have multiplied and are used as first-line therapy. ICIs include cytotoxic T-lymphocyte-associated prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfe2ba6b89d49e72f4f0d1518c803b4
https://doi.org/10.1016/j.hoc.2021.11.002
https://doi.org/10.1016/j.hoc.2021.11.002
Autor:
Parminder Singh, Irbaz Bin Riaz, Cassandra N. Moore, Heidi E. Kosiorek, Renee K. Sharpsten, Andrea McNatty, Glenn A. Stewart, Steven R. Hwang, Alan H. Bryce, Thai H. Ho, Jan B. Egan, Miguel Gonzalez Velez, Brian A. Costello
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:479-483
Background Altered tumor suppressor genes (TSG-alt) in prostate cancer are associated with worse outcomes. The prognostic value of TSG-alt in metastatic, hormone-sensitive prostate cancer (M1-HSPC) is unknown. We evaluated the effects of TSG-alt on o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f64365832daca165a52053287569af35
https://doi.org/10.1038/s41391-021-00430-4
https://doi.org/10.1038/s41391-021-00430-4
Autor:
Timothy J Voorhees, Gabriela Magarelli, Andrew M. Evens, Krista Isaac, N. Nora Bennani, Craig A. Portell, Ranjana H. Advani, Hatcher J. Ballard, Kevin A. David, Rachel Hu, Jordan Carter, Mary-Kate Malecek, Michael C. Churnetski, Tatyana Feldman, Steven R. Hwang, Eric Mou, Nancy L. Bartlett, Natalie S Grover, Jonathon B. Cohen, Jakub Svoboda, Victor M. Orellana-Noia, Brian T. Hill
Publikováno v:
Blood Adv
We performed a multicenter retrospective analysis across 10 US academic medical centers to evaluate treatment patterns and outcomes in patients age ≥60 years with classic Hodgkin lymphoma (cHL) from 2010-2018. Among 244 eligible patients, median ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06edc134a61fabab8ede5d2b05da008d
https://pubmed.ncbi.nlm.nih.gov/34448831
https://pubmed.ncbi.nlm.nih.gov/34448831
Autor:
Natalia E Castillo Almeida, Alexandra Higgins, Betsy LaPlant, Thomas E. Witzig, N. Nora Bennani, Gita Thanarajasingam, Matthew J. Maurer, Stephen M. Ansell, Steven R. Hwang
Publikováno v:
Leukemialymphoma. 62(1)
Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic landscape of cancer over the past decade with significant improvement in survival for patients with metastatic melanoma, lung...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1dc1c81c6b87e8a38f96c16de444cf
https://pubmed.ncbi.nlm.nih.gov/33021136
https://pubmed.ncbi.nlm.nih.gov/33021136